Your browser doesn't support javascript.
loading
Corrigendum to "A randomised phase II study investigating durvalumab in addition to an anthracycline taxane-based neoadjuvant therapy in early triple-negative breast cancer: clinical results and biomarker analysis of GeparNuevo study": [Annals of Oncology (2019), volume 30:1279-1288].
Loibl, S; Untch, M; Burchardi, N; Huober, J; Sinn, B V; Blohmer, J-U; Grischke, E-M; Furlanetto, J; Tesch, H; Hanusch, C; Engels, K; Rezai, M; Jackisch, C; Schmitt, W D; von Minckwitz, G; Thomalla, J; Kümmel, S; Rautenberg, B; Fasching, P A; Weber, K; Rhiem, K; Denkert, C; Schneeweiss, A.
Afiliação
  • Loibl S; German Breast Group, Neu-Isenburg; Oncological Practice Bethanien, Cancer Center Frankfurt Northeast, Frankfurt am Main. Electronic address: sibylle.loibl@gbg.de.
  • Untch M; HELIOS Klinikum Berlin-Buch, Berlin.
  • Burchardi N; German Breast Group, Neu-Isenburg.
  • Huober J; Brustzentrum, Universitätsfrauenklinik Ulm, Ulm.
  • Sinn BV; Institute of Pathology, Charité-Universitätsmedizin Berlin, Berlin; Berlin Institute of Health (BIH), Berlin.
  • Blohmer JU; Gynäkologie mit Brustzentrum, Charité-Universitätsmedizin Berlin, Berlin.
  • Grischke EM; Universitätsfrauenklinik Tübingen, Tübingen.
  • Furlanetto J; German Breast Group, Neu-Isenburg.
  • Tesch H; Oncological Practice Bethanien, Cancer Center Frankfurt Northeast, Frankfurt am Main.
  • Hanusch C; Rotkreuzklinikum München Frauenklinik, München.
  • Engels K; Zentrum für Pathologie, Zytologie und Molekularpathologie Neuss, Neuss.
  • Rezai M; Medical Center, Luisenkrankenhaus Düsseldorf, Düsseldorf.
  • Jackisch C; Brustzentrum, Sana-Klinikum Offenbach, Offenbach.
  • Schmitt WD; Institute of Pathology, Charité-Universitätsmedizin Berlin, Berlin.
  • von Minckwitz G; German Breast Group, Neu-Isenburg.
  • Thomalla J; Praxisklinik für Hämatologie und Onkologie Koblenz, Koblenz.
  • Kümmel S; Breast Unit, Kliniken Essen-Mitte, Essen.
  • Rautenberg B; Klinik für Frauenheilkunde, Universitätsklinikum Freiburg, Freiburg.
  • Fasching PA; Brustzentrum, Universitätsklinikum Erlangen, Erlangen.
  • Weber K; German Breast Group, Neu-Isenburg.
  • Rhiem K; Center for Hereditary Breast and Ovarian Cancer, University Hospital Cologne, Cologne.
  • Denkert C; Institute of Pathology, Charité-Universitätsmedizin Berlin, Berlin.
  • Schneeweiss A; National Center for Tumor Diseases, University Hospital Heidelberg, Heidelberg, Germany.
Ann Oncol ; 33(7): 743-744, 2022 Jul.
Article em En | MEDLINE | ID: mdl-35595658
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Ano de publicação: 2022 Tipo de documento: Article